Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: INSTITUT DE FORMULATION DES VACCINS (CH) SA
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-30 to 2028-09-29
Current total value of award: $1449048
Description: ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES